Sarcoma of the jaws is a rare, aggressive malignancy with a 5-year survival rate ranging between 27% and 84%. The purpose of the present study is to present our experience with a cohort of 11 patients treated in two departments of Oral and maxillofacial Surgery. We present the experience ...
This 18% survival rate is comparable to the results of therapy at Memorial Hospital for osteogenic sarcoma as a group. These data indicate to us that whereas telangiectatic osteogenic sarcoma is a distinct histologic entity, distinguishing this type is academic since there is no prognostic ...
In Gleidman, Horowitz, and Lewis's series, the five-year survival rate for sarcoma was I 5 per cent.doi:10.1016/S0022-3468(74)80359-3Anthony H. AlterElsevier Inc.Journal of Pediatric Surgery
Prior to the development of chemotherapeutic techniques the prognosis from osteosarcoma was universally poor, with a 5 year survival rate of less than 20%. However, a localised osteosarcoma is now associated with a 5 year survival rate of approximately 60%. How is Osteosarcoma (Osteogenic sarcoma)...
Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experience Two hundred seventy-nine consecutive patients with Stage II osteogenic sarcoma of the appendicular skeleton treated between 1976 and 1986 were studied to identify predictors of long-term survival. Survival...
Osteogenic sarcoma of the jaw: a 10-year experience Patients had a higher survival rate for tumours in this site than is normal for other parts of the body. [ FROM AUTHOR] None - 《British Dental Journal》 被引量: 87发表: 2008年 Primary osteogenic sarcoma of the femur: a model for ...
The survival rate of MSCs after transfection could have been up to 90% in our conditions at the concentration of 50 nM based on our early experiments. The results showed that MSCs transfected with miR-708 mimic at 48 h significantly increased the expression level of hsa-mir-708 in ...
Beron, G, Euler, A, Winkler, K (1985) Pulmonary metastases from osteogenic sarcoma: complete resection and effective chemotherapy contributing to improved prognosis. Eur J Paediatr Haematol Oncol 2: pp. 77-85Beron G, Euler A, Winkler K. Pulmonary metastases from osteogenic sarcoma: complete ...
Evaluates the role of chemotherapy with a combination of doxorubicin and cisplatin in high-grade, nonosteogenic, non-Ewing's sarcoma of the bone. Surgical interventions; Comparison of disease-free survival and overall survival rate of patients with or without chemotherapy; Relapse incidence after chemo...
Head and neck OS are associated with a lower metastatic rate than long bone OS, and they have a better 5-year survival rate, ranging between 27% and 84%. Patients and Methods We present our experience at the Department of Oral and Maxillofacial Surgery, University of Maryland, Baltimore, ...